BETA

Activities of Pavel POC related to 2017/2030(INI)

Plenary speeches (1)

Implementation of the 7th Environment Action Programme (debate) CS
2016/11/22
Dossiers: 2017/2030(INI)

Amendments (12)

Amendment 23 #
Motion for a resolution
Recital C a (new)
Ca. whereas the continuing failure to implement legislation and integrate specialised knowledge into policy-making in areas such as air quality, environmental noise and exposure to chemicals poses severe health threats and reduces quality and length of life for EU citizens;
2017/12/08
Committee: ENVI
Amendment 50 #
Motion for a resolution
Paragraph 4 a (new)
4a. Welcomes existing initiatives which contribute to reducing knowledge gaps, including: the ‘Driving Force - Pressure - State - Exposure - Effects - Action’ (DPSEEA) model for understanding the drivers which disrupt ecosystem services; the ‘health belief’ model (HBM) for estimating exposure of human populations to contaminants and the possible health effects thereof; and the ‘Information Platform for Chemical Monitoring’ (IPCheM);
2017/12/08
Committee: ENVI
Amendment 62 #
Motion for a resolution
Paragraph 5 a (new)
5a. Underlines that the combination of complex, systemic risks to health with uncertainties and gaps in the current knowledge base requires a strict adherence to the precautionary principle;
2017/12/08
Committee: ENVI
Amendment 63 #
Motion for a resolution
Paragraph 5 b (new)
5b. Deplores that the Commission failed to meet the deadline for drafting harmonised hazard-based criteria for the identification of endocrine disruptors set out by law;
2017/12/08
Committee: ENVI
Amendment 65 #
Motion for a resolution
Paragraph 5 c (new)
5c. Deplores that there has not been satisfactory development on setting out a comprehensive approach to minimising exposure to hazardous substances, including chemicals in products;
2017/12/08
Committee: ENVI
Amendment 66 #
Motion for a resolution
Paragraph 5 d (new)
5d. Regrets that the Union so far failed to make progress in developing a Union strategy for a non-toxic environment that is conducive to innovation and the development of sustainable substitutes including non- chemical solutions, building on horizontal measures to be undertaken by 2015 to ensure: the safety of manufactured nanomaterials and materials with similar properties; the minimisation of exposure to endocrine disruptors; appropriate regulatory approaches to address combination effects of chemicals and the minimisation of exposure to chemicals in products, including, inter alia, imported products, with a view to promoting non- toxic material cycles and reducing indoor exposure to harmful substances;
2017/12/08
Committee: ENVI
Amendment 67 #
Motion for a resolution
Paragraph 5 e (new)
5e. Regrets that the Commission’s obligation to review the Cosmetics Regulation with regard to endocrine disruptors no later than January 2015 has not been fulfilled despite several reminders from consumers’ and health organisations, the Parliament and scientific community and despite the Commission’s commitment that they would finalise the review by the end of 2016; calls on the Commission to immediately review the Cosmetics Regulation with regard to endocrine disruptors without any further delays;
2017/12/08
Committee: ENVI
Amendment 68 #
Motion for a resolution
Paragraph 5 f (new)
5f. Highlights that efforts need to be stepped up to ensure that, by 2020, all relevant substances of very high concern, including substances with endocrine- disrupting properties, are placed on the REACH candidate list;
2017/12/08
Committee: ENVI
Amendment 145 #
Motion for a resolution
Paragraph 15
15. Requests that the relevant EU institutions and agencies prioritise research and close knowledge gaps in the following areas: environmental thresholds (tipping points), the circular economy paradigm, the interplay between socio-economic and environmental factors, production and consumption patterns, the costs / benefits of action or inaction, the combined effects of chemicals, and nanomaterials, hazard identification methods, PBT substances, the impacts of microplastics, ultra fine particles, pharmaceuticals in the environment, the interaction between systemic risks and other health determinants, the impact of single stressors on health over the long term, soil and land use and invasive alien species;
2017/12/08
Committee: ENVI
Amendment 158 #
Motion for a resolution
Paragraph 16 a (new)
16a. In order to safeguard the Union’s citizens from environment-related pressures and risks to health and well- being, calls on the Commission and the Member States to ensure that the combination effects of chemicals and safety concerns related to endocrine disruptors are effectively addressed in all relevant Union legislation, and risks for the environment and health, in particular in relation to children, associated with the use of hazardous substances, including chemicals in products, are assessed and minimised by 2020;
2017/12/08
Committee: ENVI
Amendment 161 #
Motion for a resolution
Paragraph 16 b (new)
16b. Calls on the Commission to ensure that long-term actions with a view to reaching the objective of a non-toxic environment will be identified by 2020;
2017/12/08
Committee: ENVI
Amendment 169 #
Motion for a resolution
Paragraph 17 a (new)
17a. Calls on the Commission to fully apply the precautionary principle when sufficient data is not available; highlights the cases of chemical and nanomaterials as relevant examples;
2017/12/08
Committee: ENVI